Skip to main content

Table 4 Adjusted prevalence ratio (PR) for metabolic syndrome and its components, according to Nova score categories for consumption of ultra-processed foods: Study with Quilombola women in the state of Alagoas, Brazil, 2018

From: Ultra-processed food consumption and metabolic syndrome: a cross-sectional study in Quilombola communities of Alagoas, Brazil

Nova score

Adjusted PR

Model 1

Model 2

Model 3

PR (95%CI)

p

PR (95%CI)

p

PR (95%CI)

p

Arterial hypertension

  ≤ 1

Reference

-

Reference

-

Reference

-

 2

1.02 (0.80–1.30)

0.855

1.03 (0.81–1.31)

0.820

1.01 (0.79–1.29)

0.930

 3

1.24 (0.87–1.76)

0.234

1.21 (0.84–1.73)

0.304

1.22 (0.85–1.74)

0.274

  ≥ 4

0.95 (0.60–1.50)

0.818

0.95 (0.60–1.50)

0.826

0.89 (0.57–1.42)

0.640

Diabetes mellitus (HbA1C ≥ 6,5 mg/dL)

  ≤ 1

Reference

-

Reference

-

Reference

-

 2

0.97 (0.74–1.26)

0.820

0.99 (0.76–1.29)

0.917

0.92 (0.70–1.21)

0.5432

 3

0.56 (0.31–0.98)

0.044

0.59 (0.33–1.03)

0.065

0.56 (0.31–0.99)

0.046

  ≥ 4

0.82 (0.49–1.44)

0.517

085 (0.49–1.46)

0.557

0.82 (0.47–1,43)

0.492

Abdominal obesity (waist circumference ≥ 80 cm)

  ≤ 1

Reference

-

Reference

-

Reference

-

 2

0.96 (0.86–1.07)

0.466

0.96 (0.86–1.07)

0.455

0.98 (0.91–1.05)

0.506

 3

1.06 (0.91–1.23)

0.462

1.06 (0.91–1.24)

0.456

1.03 (0.93–1.14)

0.573

  ≥ 4

0,98(0.80–1.21)

0.868

0.98 (0.80–1.20)

0.852

0.93 (0.83–1.05)

0.233

HDL low (HDL < 50 mg/dL)

     

  ≤ 1

Reference

-

Reference

-

Reference

-

 2

0.91 (0.82–1.01)

0.068

0.91 (0.82–1.01)

0.067

0.90 (0.81–0.99)

0.046

 3

1.01 (0.89–1.15)

0.875

1.02 (0.90–1.16)

0.689

1.01 (0.90–1.15)

0.880

  ≥ 4

1.01 (0.86–1.16)

0.968

1.01 (0.86–1.16)

0.972

0.99 (0.86–1.15)

0.942

Hypertriglyceridemia (Triglycerides ≥ 175 mg/dL)

  ≤ 1

Reference

-

Reference

-

Reference

-

 2

1.01 (0.81–1.25)

0.976

1.01 (0.81–1.26)

0.934

1.01 (0.82–1.25)

0.911

 3

1.22 (0.89–1.67)

0.215

1.21 (0.88–1.67)

0.246

1.23 (0.90–1.69)

0.195

  ≥ 4

0.83 (0.53–1.31)

0.428

0.83 (0.53–1.31)

0.427

0.79 (0.50–1.26)

0.322

Metabolic syndrome

  ≤ 1

Reference

-

Reference

-

Reference

-

 2

0.97 (0.81–1.16)

0,744

0.97 (0.81–1.16)

0.741

1.01 (0.86–1.20)

0.881

 3

1.16 (0.90–1.50)

0.244

1.20 (0.93–1.54)

0.161

1.21 (0.94–1.56)

0.131

  ≥ 4

0.97 (0.70–1.35)

0.858

0.97 (0.70–1.35)

0.860

0.90 (0.67–1,22)

0.507

  1. PR Prevalence ratios, 95%CI 95% confidence intervals
  2. Model 1: Adjusted for demographic and socioeconomic characteristics whose in the crude analysis showed p ≤ 0.20 (age, race/skin color, marital status, schooling, family participation in a government program, family income, employment status and food insecurity—See Supplementary Table 4
  3. Model 2: Adjusted for lifestyle and health variables whose in the crude analysis showed p ≤ 0.20 (smoking and health problems in the last 15 days) added to the variables of model 1 that showed p < 0.05 in the analysis for the aforementioned model (these variables were different for each outcome evaluated; only age was present in the analysis for all outcomes)—See Supplementary Table 4
  4. Model 3: adjusted for anthropometric variables whose in the crude analysis showed p ≤ 0.20 (excess weight and neck circumference) plus the variables from model 1 that showed p < 0.05 in the analysis of the model 1 (these variables were different for each assessed outcome; only age was present in the analysis for all outcomes). Lifestyle and health variables were not part of this final model as they did not present p < 0.05 in the analysis of model 2—See Supplementary Table 4
Back to article page

International Journal for Equity in Health

ISSN: 1475-9276

Contact us